Navigation Links
Cardica Announces Proposed Public Offering of Common Stock
Date:10/29/2007

REDWOOD CITY, Calif., Oct. 29 /PRNewswire-FirstCall/-- Cardica, Inc. (Nasdaq: CRDC) today announced that it plans to offer, subject to market and other conditions, 1,500,000 shares of its common stock for sale by Cardica and 2,579,795 shares of its common stock for sale by a selling stockholder in an underwritten public offering. Cardica will not receive any proceeds from sales of shares made by the selling stockholder. Cardica expects to grant the underwriters a 30-day option to purchase up to an additional 611,969 shares of common stock from Cardica to cover over-allotments, if any.

William Blair & Company, L.L.C. is acting as the sole book-running manager of the offering. Allen & Company LLC, Needham & Company, LLC and Merriman Curhan Ford & Co. will act as co-managers of the offering.

These shares will be issued pursuant to a currently effective shelf registration statement. This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offer, if at all, will be made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. Printed copies of the preliminary prospectus supplement and base prospectus relating to the offering may be obtained, when available, from: William Blair & Company, L.L.C., Prospectus Department, 222 West Adams Street, Chicago, Illinois 60606, (312) 236-1600. Cardica intends to file a preliminary prospectus supplement relating to the offering with the S
'/>"/>

SOURCE Cardica, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...might want to have another look at that attractive...ording to recent studies, teenage girls who read a...es, are more prone to resort to drastic weight red...ing, laxatives or smoking more cigarettes, than th...
...y a figment of imagination. The feelings associate...that homesickness can be prevented or tackled// at...to an intense form. A recent study shows that ap...leave home to be part of some camp feel miserable ...
...VD) left an indelible impact on the lives of many ...ted due the disease. The most recent data enable...the highest fatality rate due to CVD, at 406 death...trayed the lowest death rate from CVD, about 221 d...
...els of symptoms of Post-Traumatic Stress Disorder ... people of the same age without the disorder, a ne...D) is a serious, potentially debilitating conditio...perienced or witnessed a life-threatening event, s...
Other Medicine News:Health News:Drop That Glossy, Girl! 2Health News:Coping With Homesickness 2
(Date:9/4/2008)... designation for the treatment of Acute Myeloid ... N.J., Sept. 4 /- Celator Pharmaceuti...inistration (FDA) has granted orphan,drug designat...Injection,for the treatment of Acute Myeloid Leuke...duct two randomized Phase 2,studies with CPX-351. ...
(Date:9/4/2008)...aqMan(R) real-time PCR testing for the diagnostic ... Calif., Sept. 4 /- The U.S. Food & D...BAS(R) TaqMan(R) HBV Test,the first assay for qua...S.,The test uses Roche,s real-time PCR technology ... a patient,s blood. Doctors may use viral load,tes...
(Date:9/4/2008)... Obstetrician-Gynecologists States UFE Meets Level... Invasive Interventional,Radiology Treatment Is Sa...ds, FAIRFAX, Va., Sept. 4 /PRNewswire-USNewswire/...ional organization of nearly 4,500 doctors,scient...improving health,care through minimally invasive t...
(Date:9/4/2008)...nroll 750 Women at More Than 100 Sites in the U.S....x Pharmaceuticals, a,privately-held biopharmaceuti...zation of compounds to treat endocrine, metabolic ... it has initiated a second,Phase 3 clinical trial ...estrogen-free oral therapy in development for the ...
Breaking Medicine Technology:Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2 2007 2518 1Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2 2007 2518 2Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2 2007 2518 3Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2 2007 2518 4Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting 962 1Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting 962 2UVA researchers explain cell response to skin damaging UV rays 631 1UVA researchers explain cell response to skin damaging UV rays 631 2Innovator Award to Berkeley Labs Joe Gray for improved breast cancer screening 2510 1Innovator Award to Berkeley Labs Joe Gray for improved breast cancer screening 2510 2Innovator Award to Berkeley Labs Joe Gray for improved breast cancer screening 2510 3Innovator Award to Berkeley Labs Joe Gray for improved breast cancer screening 2510 4
...bility,Significantly Longer than Placebo and had a...h Placebo , MARIETTA, Ga. and COLLEGEVILLE, Pa., M...Pharmaceuticals, a division of Wyeth,(NYSE:WYE), a...n,bifeprunox, an investigational treatment for adu... the 2007 annual meeting of,the American Psychiatr...
...EL XR--, WILMINGTON, Del., May 22, 2007 /PRNewswir...wo analyses from a large-scale,study that investig...umarate) Extended-Release Tablets, a once-daily me... patients, were presented today,at the annual meet... These analyses from the clinical trial data for S...
Other Medicine Technology:New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 2New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 4New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 2New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 6New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 7New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 8New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 9
Clearview C. Diff A is a one-step test for the direct qualitative detection of Clostridium difficile toxin A from fecal samples.
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults.
...est is one of the easiest tests to run on the mark...s with no hands-on time. Critical care instruction...aving the pediatrician's office and valuable infor... to help control the spread of RSV infections. Now...
The BinaxNOW Influenza A & B Test simplifies rapid influenza testing. The easiest flu test on the market just got easier with accurate differentiation between influenza A and influenza B using one si
Medicine Products: